{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T01:07:05Z","timestamp":1780967225260,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computer Methods and Programs in Biomedicine"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.cmpb.2025.108678","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T07:53:58Z","timestamp":1739865238000},"page":"108678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["In silico tuning of binding selectivity for new SARS-CoV-2 main protease inhibitors"],"prefix":"10.1016","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6584-0516","authenticated-orcid":false,"given":"Feng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0817-5641","authenticated-orcid":false,"given":"Vladislav","family":"Vasilyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmpb.2025.108678_bib0001","article-title":"Structure and function of SARS-CoV and SARS-CoV-2 main proteases and their inhibition: a comprehensive review","author":"Li","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cmpb.2025.108678_bib0002","article-title":"Structural-property relationship in halogen-bonded Schiff base derivative: crystal structure, computational and SARS-CoV-2 docking studies","volume":"1265","author":"Kumar","year":"2022","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.cmpb.2025.108678_bib0003","unstructured":"Department of Health and Aged Care. 2025, Available from: https:\/\/www.health.gov.au\/covid-19\/reporting."},{"key":"10.1016\/j.cmpb.2025.108678_bib0004","unstructured":"National Notifiable Disease Surveillance System. 2025, Available from: https:\/\/nindss.health.gov.au\/pbi-dashboard\/."},{"issue":"8","key":"10.1016\/j.cmpb.2025.108678_bib0005","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.3390\/microorganisms8081250","article-title":"Progress in developing inhibitors of SARS-CoV-2 3C-like protease","volume":"8","author":"Li","year":"2020","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.cmpb.2025.108678_bib0006","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1080\/07853890.2022.2031274","article-title":"Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines","volume":"54","author":"Fernandes","year":"2022","journal-title":"Ann. Med."},{"issue":"7","key":"10.1016\/j.cmpb.2025.108678_bib0007","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2174\/1568026623666221229113456","article-title":"Bioinformatics paradigms in drug discovery and drug development","volume":"23","author":"Sharma","year":"2023","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.cmpb.2025.108678_bib0008","unstructured":"Anon, Genomic epidemiology of SARS-CoV-2 with subsampling focused globally over the past 6 months. 08\/10\/2024]; Available from: (https:\/\/nextstrain.org\/ncov\/gisaid\/global\/6m)."},{"key":"10.1016\/j.cmpb.2025.108678_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2021.131879","article-title":"Dietary polyphenols mitigate SARS-CoV-2 main protease (Mpro)\u2013Molecular dynamics, molecular mechanics, and density functional theory investigations","volume":"1250","author":"Adelusi","year":"2022","journal-title":"J. Mol. Struct."},{"issue":"16","key":"10.1016\/j.cmpb.2025.108678_bib0010","doi-asserted-by":"crossref","first-page":"9121","DOI":"10.1039\/D0CS01065K","article-title":"A critical overview of computational approaches employed for COVID-19 drug discovery","volume":"50","author":"Muratov","year":"2021","journal-title":"Chem. Soc. Rev."},{"issue":"7811","key":"10.1016\/j.cmpb.2025.108678_bib0012","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.cmpb.2025.108678_bib0013","first-page":"1","article-title":"Both baicalein and gallocatechin gallate effectively inhibit SARS-CoV-2 replication by targeting M pro and sepsis in mice","author":"Xiao","year":"2022","journal-title":"Inflammation"},{"issue":"9","key":"10.1016\/j.cmpb.2025.108678_bib0014","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41401-020-0483-6","article-title":"Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients","volume":"41","author":"Su","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cmpb.2025.108678_bib0015","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2022.04.086","article-title":"Crystal structure of SARS-CoV 3C-like protease with baicalein","volume":"611","author":"Feng","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"20","key":"10.1016\/j.cmpb.2025.108678_bib0016","doi-asserted-by":"crossref","first-page":"e26765","DOI":"10.1002\/qua.26765","article-title":"Accelerating optical reporting for conformation of tyrosine kinase inhibitors in solutions","volume":"121","author":"Wang","year":"2021","journal-title":"Int. J. Quantum Chem."},{"key":"10.1016\/j.cmpb.2025.108678_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2024.173804","article-title":"From past to future: 50 years of pharmacological interventions to treat narcolepsy","author":"Konofal","year":"2024","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.cmpb.2025.108678_bib0017","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1039\/D1NJ04348J","article-title":"Optical spectra and conformation pool of tyrosine kinase inhibitor PD153035 using a robust quantum mechanical conformation search","volume":"46","author":"Wang","year":"2022","journal-title":"New J. Chem."},{"issue":"2","key":"10.1016\/j.cmpb.2025.108678_bib0019","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1039\/D1ME00124H","article-title":"Thermodynamic and structural insights into the repurposing of drugs that bind to SARS-CoV-2 main protease","volume":"7","author":"Wan","year":"2022","journal-title":"Mol. Syst. Des. Eng."},{"key":"10.1016\/j.cmpb.2025.108678_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2024.1292280","article-title":"Identification of potential therapeutic targets for COVID-19 through a structural-based similarity approach between SARS-CoV-2 and its human host proteins","volume":"15","author":"Tasneem","year":"2024","journal-title":"Front. Genet."},{"key":"10.1016\/j.cmpb.2025.108678_bib0021","unstructured":"G\u00fcnther, S., et al., Massive X-ray screening reveals two allosteric drug binding sites of SARS-CoV-2 main protease. bioRxiv, 2020: p. 2020.11. 12. 378422."},{"issue":"1","key":"10.1016\/j.cmpb.2025.108678_bib0022","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s43141-020-00085-z","article-title":"A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods","volume":"18","author":"Singh","year":"2020","journal-title":"J. Genet. Eng. Biotechnol."},{"issue":"11","key":"10.1016\/j.cmpb.2025.108678_bib0023","doi-asserted-by":"crossref","DOI":"10.1063\/5.0019056","article-title":"A fast and high-quality charge model for the next generation general AMBER force field","volume":"153","author":"He","year":"2020","journal-title":"J. Chem. Phys."},{"issue":"2","key":"10.1016\/j.cmpb.2025.108678_bib0024","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/wcms.1121","article-title":"An overview of the Amber biomolecular simulation package","volume":"3","author":"Salomon-Ferrer","year":"2013","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"10.1016\/j.cmpb.2025.108678_bib0025","unstructured":"Frisch, M.J., Trucks, G.W., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R., Scalmani, G., Barone, V., Petersson, G.A., Fox, D.J.; et al., Gaussian 16, Revision A.03; Gaussian, Inc.: Wallingford CT, 2016. 2016."},{"issue":"12","key":"10.1016\/j.cmpb.2025.108678_bib0026","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1021\/ar000033j","article-title":"Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models","volume":"33","author":"Kollman","year":"2000","journal-title":"Acc. Chem. Res."},{"issue":"12","key":"10.1016\/j.cmpb.2025.108678_bib0027","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/cpb.c23-00562","article-title":"Exploratory studies of effective inhibitors against the SARS-CoV-2 main protease by Halogen incorporation and amide bond replacement","volume":"71","author":"Tsuji","year":"2023","journal-title":"Chem. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.cmpb.2025.108678_bib0028","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1021\/acs.jcim.1c01304","article-title":"Halogenated baicalein as a promising antiviral agent toward SARS-CoV-2 main protease","volume":"62","author":"Hengphasatporn","year":"2022","journal-title":"J. Chem. Inf. Model."},{"issue":"1","key":"10.1016\/j.cmpb.2025.108678_bib0029","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/s41467-022-29413-2","article-title":"Development of optimized drug-like small molecule inhibitors of the SARS-CoV-2 3CL protease for treatment of COVID-19","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.cmpb.2025.108678_bib0030","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.3390\/molecules29122800","article-title":"Insights into halogen-induced changes in 4-anilinoquinazoline EGFR inhibitors: a computational spectroscopic study","volume":"29","author":"Alagawani","year":"2024","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.cmpb.2025.108678_bib0031","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.cmpb.2025.108678_bib32","doi-asserted-by":"crossref","first-page":"114367","DOI":"10.1016\/j.jep.2021.114367","article-title":"Efficacy and safety of ReDuNing injection as a treatment for COVID-19 and its inhibitory effect against SARS-CoV-2","volume":"279","author":"Ma","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.cmpb.2025.108678_bib33","doi-asserted-by":"crossref","first-page":"115629","DOI":"10.1016\/j.ejmech.2023.115629","article-title":"An overview of anti-SARS-CoV-2 and anti-inflammatory potential of baicalein and its metabolite baicalin: Insights into molecular mechanisms","volume":"258","author":"Dinda","year":"2023","journal-title":"Eur. J. Med. Chem."}],"container-title":["Computer Methods and Programs in Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260725000951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169260725000951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,2]],"date-time":"2025-03-02T09:47:19Z","timestamp":1740908839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169260725000951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":32,"alternative-id":["S0169260725000951"],"URL":"https:\/\/doi.org\/10.1016\/j.cmpb.2025.108678","relation":{},"ISSN":["0169-2607"],"issn-type":[{"value":"0169-2607","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico tuning of binding selectivity for new SARS-CoV-2 main protease inhibitors","name":"articletitle","label":"Article Title"},{"value":"Computer Methods and Programs in Biomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmpb.2025.108678","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"108678"}}